Variables RMP-R RMP-S Total COR (95%CI) AOR (95%CI)
Sex          
Male 57 (44.1) 72 (55.8) 129 (59.4) 1.9 (1.1-3.3) 2.2 (1.2-3.9)
Female 53 (60.2) 35 (39.8) 88 (40.6)
Age          
 ≥ 51 9 (36) 16 (64) 25 (11.5) 1 1
41-50 13 (39.4) 20 (60.6) 33 (15.2) 1.2 (0.4-3.2) 0.8 (0.3-2.6)
31-40 25 (54.3) 21 (45.7) 46 (21.2) 2.1 (0.78-5.8) 0.4 (0.2-1.2)
21-30 47 (58) 34 (42) 81 (37.3) 2.5 (1.0‑6.2) 0.4 (0.2-1.1)
Nov-20 16 (51.6) 15 (48.4) 31 (14.3) 1.9 (0.7-5.6) 0.5 (0.2-1.7)
02-Oct 0 (0) 1 (100) 1 (0.5) - -
HIV status          
Negative 65 (53.3) 57 (46.7) 122 (56.2) 1 1
Positive 18 (54.5) 15 (45.5) 33 (15.2) 1 (0.5-2.3) 1 (0.5-2.4)
Unknown 27 (43.5) 35 (56.5) 62 (28.6) 0.7 (0.4-1.3) 1.7 (0.8-3.4)
Treatment history          
New 13 (41.9) 18 (58.1) 31 (14.3) 1.5 (0.7-3.3) 0.4 (0.03-5.6)
Retreatment 97 (52.2) 89 (47.8) 186 (85.7)
TB history          
New 15 (44.1) 19 (55.9) 34 (15.7) 1 1
Relapse 40 (47.6) 44 (52.4) 84 (38.7) 1.2 (.5-2.6) 2 (0.04-91)
Failure 46 (51.1) 34 (37.8) 80 (36.9) 1.7 (0.8-3.9) 2.2 (0.2-30)
Defaulter 2 (28.6) 5 (71.4) 7 (3.22) 0.5 (0.1-3.0) 1.2 (0.9-17)
Other 0 (0) 2 (100) 2 (0.9) - 3 (0.14-69)
Unknown 7 (70) 3 (30) 10 (4.6) 3 (0.7-13.4) -
Total 110 (50.7) 107(49.3) 217 (100)    
Table 4: Logistic regression analysis showing the associated factors with MDR-TB and/or RMP-MR with socio demographic and clinical history among TB positive, presumptive MDR-TB cases, ANRS, 2013